Literature DB >> 24390763

The presence of mu-, delta-, and kappa-opioid receptors in human heart tissue.

Piotr Sobanski1, Malgorzata Krajnik, Mohammed Shaqura, Elzbieta Bloch-Boguslawska, Michael Schäfer, Shaaban A Mousa.   

Abstract

Functional evidence suggests that the stimulation of peripheral and central opioid receptors (ORs) is able to modulate heart function. Moreover, selective stimulation of either cardiac or central ORs evokes preconditioning and, therefore, protects the heart against ischemic injury. However, anatomic evidence for OR subtypes in the human heart is scarce. Human heart tissue obtained during autopsy after sudden death was examined immunohistochemically for mu- (MOR), kappa- (KOR), and delta- (DOR) OR subtypes. MOR and DOR immunoreactivity was found mainly in myocardial cells, as well as on sparse individual nerve fibers. KOR immunoreactivity was identified predominantly in myocardial cells and on intrinsic cardiac adrenergic (ICA) cell-like structures. Double immunofluorescence confocal microscopy revealed that DOR colocalized with the neuronal marker PGP9.5, as well as with the sensory neuron marker calcitonin gene-related peptide (CGRP). CGRP-immunoreactive (IR) fibers were detected either in nerve bundles or as sparse individual fibers containing varicose-like structures. Our findings offer the first hint of an anatomic basis for the existence of OR subtypes in the human heart by demonstrating their presence in CGRP-IR sensory nerve fibers, small cells with an eccentric nucleus resembling ICA cells, and myocardial cells. Taken together, this suggests the role of opioids in both the neural transmission and regulation of myocardial cell function.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24390763     DOI: 10.1007/s00380-013-0456-5

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  58 in total

1.  Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression.

Authors:  Alexander Brack; Heike L Rittner; Halina Machelska; Mohammed Shaqura; Shaaban A Mousa; Dominika Labuz; Christian Zöllner; Michael Schäfer; Christoph Stein
Journal:  Pain       Date:  2004-03       Impact factor: 6.961

Review 2.  Opioids: old drugs for potential new applications.

Authors:  U Barry; Z Zuo
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

3.  Substance P- and leu-enkephalin-immunoreactive nerves before and after myocardial ischaemia, hypothermic chemical cardioplegia and reperfusion injury during open-heart surgery.

Authors:  K T Kyösola; K Aalto-Setälä; A L Harjula; S Mattila; L Rechardt
Journal:  Scand J Thorac Cardiovasc Surg       Date:  1986

4.  Are opioid peptides co-transmitters in noradrenergic vesicles of sympathetic nerves?

Authors:  S P Wilson; R L Klein; K J Chang; M S Gasparis; O H Viveros; W H Yang
Journal:  Nature       Date:  1980-12-25       Impact factor: 49.962

Review 5.  Opioids and cardioprotection.

Authors:  J E Schultz; G J Gross
Journal:  Pharmacol Ther       Date:  2001-02       Impact factor: 12.310

6.  Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord.

Authors:  U Arvidsson; M Riedl; S Chakrabarti; J H Lee; A H Nakano; R J Dado; H H Loh; P Y Law; M W Wessendorf; R Elde
Journal:  J Neurosci       Date:  1995-05       Impact factor: 6.167

7.  Beta-endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis.

Authors:  Shaaban A Mousa; Rainer H Straub; Michael Schäfer; Christoph Stein
Journal:  Ann Rheum Dis       Date:  2007-02-26       Impact factor: 19.103

8.  Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle.

Authors:  S P Bell; M N Sack; A Patel; L H Opie; D M Yellon
Journal:  J Am Coll Cardiol       Date:  2000-12       Impact factor: 24.094

9.  Kappa and delta opioid receptor signaling is augmented in the failing heart.

Authors:  Craig Bolte; Gilbert Newman; Jo El J Schultz
Journal:  J Mol Cell Cardiol       Date:  2009-06-30       Impact factor: 5.000

Review 10.  Role of opioids in acute and delayed preconditioning.

Authors:  Garrett J Gross
Journal:  J Mol Cell Cardiol       Date:  2003-07       Impact factor: 5.000

View more
  22 in total

1.  Transient Receptor Potential Ankyrin 1 Activation within the Cardiac Myocyte Limits Ischemia-reperfusion Injury in Rodents.

Authors:  Yao Lu; Honit Piplani; Stacy L McAllister; Carl M Hurt; Eric R Gross
Journal:  Anesthesiology       Date:  2016-12       Impact factor: 7.892

Review 2.  Risks of Opioids in ST-Elevation Myocardial Infarction: A Review.

Authors:  Anne Henrieke Tavenier; Renicus Suffridus Hermanides; Jan Paul Ottervanger; Peter Gerrit Johannes Ter Horst; Elvin Kedhi; Adriaan W J van 't Hof
Journal:  Drug Saf       Date:  2018-12       Impact factor: 5.606

Review 3.  Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart.

Authors:  John P Headrick; Louise E See Hoe; Eugene F Du Toit; Jason N Peart
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

4.  Evidence for MOR on cell membrane, sarcoplasmatic reticulum and mitochondria in left ventricular myocardium in rats.

Authors:  Sascha Treskatsch; Mohammed Shaqura; Lukas Dehe; Torsten K Roepke; Mehdi Shakibaei; Michael Schäfer; Shaaban A Mousa
Journal:  Heart Vessels       Date:  2015-12-19       Impact factor: 2.037

Review 5.  The Kappa Opioid Receptor: A Promising Therapeutic Target for Multiple Pathologies.

Authors:  Martin L Dalefield; Brittany Scouller; Rabia Bibi; Bronwyn M Kivell
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

6.  Prescription Opioid Use and Risk of Coronary Heart Disease, Stroke, and Cardiovascular Death Among Adults from a Prospective Cohort (REGARDS Study).

Authors:  Yulia Khodneva; Paul Muntner; Stefan Kertesz; Brett Kissela; Monika M Safford
Journal:  Pain Med       Date:  2016-02-08       Impact factor: 3.750

Review 7.  Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists.

Authors:  Leonid N Maslov; Igor Khaliulin; Peter R Oeltgen; Natalia V Naryzhnaya; Jian-Ming Pei; Stephen A Brown; Yury B Lishmanov; James M Downey
Journal:  Med Res Rev       Date:  2016-05-16       Impact factor: 12.944

8.  Chronic Naltrexone Therapy Is Associated with Improved Cardiac Function in Volume Overloaded Rats.

Authors:  Lukas Dehe; Mohammed Shaqura; Michael Nordine; Helmut Habazettl; Petra von Kwiatkowski; Helena Schluchter; Mehdi Shakibaei; Shaaban A Mousa; Michael Schäfer; Sascha Treskatsch
Journal:  Cardiovasc Drugs Ther       Date:  2021-01-23       Impact factor: 3.727

9.  The differential effects of a selective kappa-opioid receptor agonist, U50488, in guinea pig heart tissues.

Authors:  Chi-Feng Hung; Hsin-Ju Li; Hsun-Hao Chang; Gon-Ann Lee; Ming Jai Su
Journal:  Biomed Res Int       Date:  2015-03-01       Impact factor: 3.411

10.  Role of Opioid Receptors Signaling in Remote Electrostimulation--Induced Protection against Ischemia/Reperfusion Injury in Rat Hearts.

Authors:  Hsin-Ju Tsai; Shiang-Suo Huang; Meng-Ting Tsou; Hsiao-Ting Wang; Jen-Hwey Chiu
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.